Finch Therapeutics regains compliance with Nasdaq minimum bid price requirement

Finch Therapeutics Group, Inc.

Received letter from Nasdaq on June 27, 2023 confirming regained compliance with Listing Rule 5450(a)(1).
Closing bid price was $1.00 or greater for 10 consecutive business days from June 12 to June 26, 2023.
Previously notified of deficiency on Dec 30, 2022; compliance deadline was June 28, 2023.
Nasdaq considers the compliance matter closed; no further action required.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.